Taken together, these lines of evidence strongly support the theory that CXCR2 signaling might play an important role in KRAS-induced tumor cell-autonomous growth by directly contributing to its intracellular signaling during PDAC development and progression. The gene discussed is CXCR2; the disease is neoplasm.